Dr. Lal PathLabs' (NSE:LALPATHLAB, BOM:539524) consolidated attributable profit rose to 1.32 billion Indian rupees in the fiscal first quarter ended June 30, against 1.06 billion rupees a year ago.
Earnings per share came in at 15.85 rupees compared with 12.76 rupees a year earlier, the diagnostics services provider said in a filing to the Indian bourses on Thursday.
Revenue from operations in fiscal Q1 also increased to 6.70 billion rupees from 6.02 billion rupees a year earlier.
The company's shares were up over 1% in recent trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。